Cargando…

Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson’s disease

BACKGROUND: Parkinson’s disease (PD) is increasingly recognized as a multidimensional disorder, characterized by several non-motor symptoms, including disturbances of sleep and cognition. Current studies on the relationship between sleep problems and neuropsychological functions, mainly conducted in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montanaro, Elisa, Romagnolo, Alberto, Fabbri, Margherita, Artusi, Carlo Alberto, Imbalzano, Gabriele, Rizzone, Mario Giorgio, Lopiano, Leonardo, Zibetti, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857104/ https://www.ncbi.nlm.nih.gov/pubmed/34328543 http://dx.doi.org/10.1007/s00415-021-10726-z

Ejemplares similares

SARS-CoV-2 vaccination, Parkinson’s disease, and other movement disorders: case series and short literature review
por: Imbalzano, Gabriele, et al.
Publicado: (2022)

COVID-19 in Parkinson's disease: Report on prevalence and outcome
por: Artusi, Carlo Alberto, et al.
Publicado: (2020)

Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic
por: Montanaro, Elisa, et al.
Publicado: (2021)

Deep Brain Stimulation Outcomes in Parkinson's Disease Patients with Cognitive Impairment: Implications and Considerations
por: Romagnolo, Alberto, et al.
Publicado: (2023)

COVID-19 and Parkinson’s Disease: What Do We Know So Far?
por: Artusi, Carlo Alberto, et al.
Publicado: (2021)

Burden of caregiving for cardiovascular dysautonomia in Parkinson’s disease
por: Ledda, Claudia, et al.
Publicado: (2022)

Pisa Syndrome in Parkinson's Disease Is Associated With Specific Cognitive Alterations
por: Artusi, Carlo Alberto, et al.
Publicado: (2019)

Cohort study of neurological comorbidities and COVID-19-related case fatality
por: Imbalzano, Gabriele, et al.
Publicado: (2021)

Neurological comorbidities and COVID-19-related case fatality: A cohort study
por: Romagnolo, Alberto, et al.
Publicado: (2021)

Neurological comorbidity and severity of COVID-19
por: Romagnolo, Alberto, et al.
Publicado: (2020)

Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild COVID-19 infection
por: Piazza, Federico, et al.
Publicado: (2021)

Safety and efficacy of tolcapone in Parkinson’s disease: systematic review
por: Artusi, Carlo Alberto, et al.
Publicado: (2021)

Onset of Covid-19 with impaired consciousness and ataxia: a case report
por: Balestrino, R., et al.
Publicado: (2020)

Role of the Cingulate Cortex in Dyskinesias-Reduced-Self-Awareness: An fMRI Study on Parkinson’s Disease Patients
por: Palermo, Sara, et al.
Publicado: (2018)

Time to onset and duration of botulinum toxin efficacy in movement disorders
por: Ledda, Claudia, et al.
Publicado: (2022)

Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report
por: Bozzali, Marco, et al.
Publicado: (2021)

How resistant are levodopa‐resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease
por: Imbalzano, Gabriele, et al.
Publicado: (2022)

Assessment of Axial Postural Abnormalities in Parkinsonism: Automatic Picture Analysis Software
por: Artusi, Carlo Alberto, et al.
Publicado: (2023)

Should we offer deep brain stimulation to Parkinson’s disease patients with GBA mutations?
por: Artusi, Carlo Alberto, et al.
Publicado: (2023)

Deep Brain Stimulation Selection Criteria for Parkinson’s Disease: Time to Go beyond CAPSIT-PD
por: Artusi, Carlo Alberto, et al.
Publicado: (2020)

Camera- and Viewpoint-Agnostic Evaluation of Axial Postural Abnormalities in People with Parkinson’s Disease through Augmented Human Pose Estimation
por: Aldegheri, Stefano, et al.
Publicado: (2023)

The Dominant-Subthalamic Nucleus Phenomenon in Bilateral Deep Brain Stimulation for Parkinson’s Disease: Evidence from a Gait Analysis Study
por: Rizzone, Mario Giorgio, et al.
Publicado: (2017)

What Happens When I Watch a Ballet and I Am Dyskinetic? A fMRI Case Report in Parkinson Disease
por: Palermo, Sara, et al.
Publicado: (2020)

Cognitive dysfunction in non-demented patients with Parkinson's disease
por: Zalonis, Ioannis, et al.
Publicado: (2010)

Single‐channel EEG classification of sleep stages based on REM microstructure
por: Rechichi, Irene, et al.
Publicado: (2021)

Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials
por: Merola, Aristide, et al.
Publicado: (2021)

Alexithymia in patients with Parkinson’s disease treated with DBS of the subthalamic nucleus: a case-control study
por: Castelli, Lorys, et al.
Publicado: (2014)

Differential impact of individual autonomic domains on clinical outcomes in Parkinson’s disease
por: Longardner, Katherine, et al.
Publicado: (2022)

Longitudinal Assessment of Botulinum Toxin Treatment for Lateral Trunk Flexion and Pisa Syndrome in Parkinson’s Disease: Real-life, Long-Term Study
por: Ledda, Claudia, et al.
Publicado: (2023)

Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis
por: Artusi, Carlo Alberto, et al.
Publicado: (2019)

Discovery and verification of panels of T-lymphocyte proteins as biomarkers of Parkinson's disease
por: Alberio, Tiziana, et al.
Publicado: (2012)

Impulse control disorder and response-inhibition alterations in Parkinson’s disease. A rare case of totally absent functionality of the medial-prefrontal cortex and review of literature
por: Palermo, Sara, et al.
Publicado: (2017)

Impulsivities and Parkinson's Disease: Delay Aversion Is Not Worsened by Deep Brain Stimulation of the Subthalamic Nucleus
por: Torta, Diana M. E., et al.
Publicado: (2012)

Emotion Processing in Parkinson’s Disease: A Three-Level Study on Recognition, Representation, and Regulation
por: Enrici, Ivan, et al.
Publicado: (2015)

A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson’s disease patients
por: Barone, P, et al.
Publicado: (2015)

Does the Degree of Trunk Bending Predict Patient Disability, Motor Impairment, Falls, and Back Pain in Parkinson's Disease?
por: Geroin, Christian, et al.
Publicado: (2020)

Neuropsychiatric co-morbidities in non-demented Parkinson's disease
por: Rai, Nirendra Kumar, et al.
Publicado: (2015)

Efficacy of amantadine in patients hospitalized with COVID-19: Study protocol of a randomized, double-blind, placebo-controlled trial
por: Lopiano, Leonardo, et al.
Publicado: (2021)

Verbal Fluency Performance in Patients with Non-demented Parkinson's Disease
por: Dadgar, Hooshang, et al.
Publicado: (2013)

The Prevalence of Cerebral Microbleeds in Non-Demented Parkinson's Disease Patients
por: Kim, Kyeong Joon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jfg284nd88vap197a2mgeho9ql